Outside of cancer immunotherapy, Bristol-Myers Squibb is interested in pursuing five areas: Heart failure, virology, rare disease, immunoscience and fibrosis.
Donnie McGrath, a vp at Bristol-Myers Squibb and head of search and evaluation, discussed business development strategy in an interview at this week’s Redefining Early Stage Investments (RESI) conference in Houston.
Hey, check out all the research scientist jobs. Post your resume today!
